世界500强企业PPT地28.pptxVIP

世界500强企业PPT地图设计GENERICS: A $90B GLOBAL OPPORTUNITYWestern Europe$17bnEastern Europe Russia: $10bnChina: $3bnUS, Canada: $50bnJapan: $4bnRest of World: $4bnLatin America: $2bnTotal World Pharmaceutical Sales: $600bnSource: TS Research, IMS Health, VOI PharmaHandbookExpanding internationally?2008 Expedia, Inc. Confidential proprietary. All rights reserved.International investing dynamicsDomestic investingU.S. onlyGlobal investingU.S. and ForeignInternational investingForeign only■U.S.■ForeignAXA Retirement Scope MethodologyGeographical coverage: a total of 9,200 people interviewed in 15 countries.NetherlandsBelgiumCanadaUKGermanyFranceSpain Arial 14JapanUnited StatesPortugalItalyHong KongSingapore Arial 14AustraliaNew ZealandBase : n=300 working, n=300 retiredSpecifically for the US: n=403 working, n=410 retiredActive in 12 countries in Europe AsiaSituation on 31 December 2013Belgium - 75%Life € 4,101 mioNon-Life: € 1,855 mioUK – 100%Life: € 108 mioNon-Life: € 2,176 mioChina - 25%Life: € 6,397 mioLuxembourg- 33%Life: € 2,252 mioFrance - 100%Life: € 351 mioPortugal - 51%Life: € 1,486 mioNon-Life: € 251 mioHong Kong - 100 %Life: € 485 mioTurkey - 36%Non-Life: € 602 mioThailandLife – 31%: € 1,476 mioNon-Life– 15%: € 214 mioItaly - 25%Non-Life: € 211 mioIndia - 26%Life: € 108 mioMalaysia - 31% Life: € 594 mioNon-Life: € 552 mio* Inflow included non-consolidated partnerships @ 100%Ageas Clubhina (2001)Net investment of EUR 390m composed of EUR 397m investments and EUR-7m divestments Additional capital injections not excluded in next 3 years (2014-16) due to aggressive business plan and Greenfield Taiping e-CommerceHong Kong (2007)Net investment of EUR 686m composed of EUR 761m investments and EUR-74m dividendsSelf-supportingDividend paying since 2013India (2008)Net investment of EUR 34mGreenfield; funding requirements function of growthFirst profit recorded in 2012Malaysia (2001)Net investment of EUR 148m composed of EUR 203m investments, EUR-36m redempti